Tokyo, Sept. 17 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062948) titled 'The Reliability and Validity of the Japanese Version of the Oxford Cognitive Screen for Patients with Brain Injury' on Sept. 16.
Study Type:
Observational
Primary Sponsor:
Institute - Tokyo Metropolitan University
Condition:
Condition - BrainInjury
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The purpose of this study is to verify the validity and reliability of the Japanese version of the OCS (versions A and B) in patients with brain injury. The significance of this study lies in the fact that it can be used in clinical practice as a comprehensive cognitive assessment tool capable of easily and sensitively identifying cognitive impairment during the acute phase of brain injury.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 18
years-old
Gender - Male and Female
Key inclusion criteria - Individuals diagnosed with a stroke by a physician via CT or MRI who are able to remain seated for at least 15 minutes
Key exclusion criteria - Individuals diagnosed with dementia
Individuals diagnosed with apraxia
Individuals diagnosed with severe aphasia
Individuals diagnosed with severe hemispatial neglect
Target Size - 130
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 05 Month 07 Day
Anticipated trial start date - 2026 Year 10 Month 01 Day
Last follow-up date - 2029 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072069
Disclaimer: Curated by HT Syndication.
